As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

The wellness industry functions with little oversight and frequently relies on anecdotal accounts, intuition, and hopeful ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

We’ve known for a while that there are two Anguses—both journalists covering oncology at health- and biopharma-focused news outlets. | Two journalists, one name and a candid conversation—Angus Liu and ...

Dr. Peter Marks says the new health secretary’s team wants to show vaccines aren’t safe while promoting dangerous and unproven treatments. Liz Essley Whyte April 4, 2025 ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...